Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, John C. van Swieten, Claire Troakes et al.|Movement Disorders|2017Cited by 2.3k
<scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> recommendations for the diagnosis of <scp>P</scp>arkinson's diseaseAlfredo Berardelli, M Vidailhet, Gregor K. Wenning et al.|European Journal of Neurology|2012Cited by 490
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and ProposalsStefanie T. Jost, Marie‐Ann Kaldenbach, Angelo Antonini et al.|Movement Disorders|2023Cited by 351
Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study groupIva Stanković, Florian Krismer, Aleksandar Ješić et al.|Movement Disorders|2014Cited by 240
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive TherapiesGünther Deuschl, Elena Moro, Angelo Antonini et al.|Movement Disorders|2022Cited by 178